XML 52 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Recognized compensation expenses
The Company recognized compensation expense related to the Company plans for the years ended December 31, 2018, 2017 and 2016 as follows (in thousands):
 
 
 
2018
 
2017
 
2016
Stock option plan expense
 
$
996

 
$
1,305

 
$
538

Restricted stock expense
 
$
21,053

 
$
18,539

 
$
12,235
Summary of the activity of stock option awards
A summary of the activity of the Company’s stock options plans is presented below:
 
 
 
Shares
 
Wtd. Avg.
Exercise
Price
 
Wtd. Avg.
Remaining
Contractual Term (years)
 
Aggregate
Intrinsic
Value
 
 
(In thousands)
 
 
 
 
 
(In thousands)
Options outstanding at January 1, 2018
 
1,230

 
$
25.02

 
7.33
 
$
3,117

Granted
 
475

 
21.60

 
 
 
 
Exercised
 
(103
)
 
19.07

 
 
 
 
Forfeited/Canceled
 
(140
)
 
25.32

 
 
 
 
Options outstanding at December 31, 2018
 
1,462

 
$
24.30

 
7.20
 
$
924

Options vested and expected to vest at December 31, 2018
 
1,386

 
$
24.31

 
7.11
 
$
923

Options exercisable at December 31, 2018
 
646

 
$
23.81

 
5.59
 
$
910


The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of fiscal year 2018 and the exercise price, times the number of shares that are “in the money”) that would have been received by the option holders had all option holders exercised their options on December 31, 2018. This amount changes based on the fair value of the Company’s stock.
The following table summarizes information relative to stock option activity during the years ended December 31, 2018, 2017 and 2016 (in thousands):
 
 
 
2018
 
2017
 
2016
Intrinsic value of options exercised
 
$
519

 
$
4,126

 
$
1,671

Fair value of shares vested
 
$
794

 
$
373

 
$
518
Exercise prices and related information of stock option outstanding
The following table summarizes information about the exercise prices and related information of stock options outstanding under the Company plans at December 31, 2018:
 
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices
 
Number
Outstanding
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
Number
Exercisable
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
0-18.23
 
161

 
2.32
 
$
14.08

 
160

 
2.32
 
$
14.08

18.24-22.26
 
708

 
8.17
 
$
20.98

 
169

 
6.09
 
$
20.54

22.27-29.39
 
218

 
6.11
 
$
28.77

 
165

 
6.09
 
$
28.77

29.40-43.15
 
375

 
8.08
 
$
32.27

 
152

 
7.94
 
$
32.27

Total
 
1,462

 
7.20
 
$
24.30

 
646

 
5.59
 
$
23.81
Status of non - vested stock options
The following table summarizes the status of non-vested stock options as of December 31, 2018 and changes during the year ended December 31, 2018:
 
 
 
Number of Shares
 
Wtd. Avg. Grant
Date Fair Value
 
 
(In thousands)
 
 
Options non-vested at January 1, 2018
 
707

 
$
3.93

Granted
 
475

 
3.64

Vested
 
(226
)
 
3.21

Forfeited
 
(140
)
 
4.13

Options non-vested at December 31, 2018
 
816

 
$
3.86
Summary of the activity of restricted stock
The following table summarizes the status of restricted stock awards as of December 31, 2018 and changes during the year ended December 31, 2018:
 
 
 
Shares
 
Wtd. Avg.
Grant  date
Fair value
 
 
(In thousands)
 
 
Restricted stock outstanding at January 1, 2018
 
1,770

 
$
30.47

Granted
 
906

 
22.83

Vested
 
(584
)
 
28.50

Forfeited/Canceled
 
(74
)
 
25.04

Restricted stock outstanding at December 31, 2018
 
2,018

 
$
27.62